The Endolymph Signal in Non-contrast Enhanced 3D-real IR Image Differs between the Ears with and without Significant Endolymphatic Hydrops

在非对比增强的3D真实红外图像中,有明显内淋巴积水的耳朵和无明显内淋巴积水的耳朵的内淋巴信号存在差异。

阅读:1

Abstract

PURPOSE: To investigate whether significant differences exist in labyrinthine lymph fluid signal intensities on non-contrast-enhanced 3D real inversion recovery (3D-real IR) images between patients with and without significant endolymphatic hydrops (EH), potentially enabling the non-contrast detection of EH. METHODS: Thirty-nine patients suspected of having EH underwent 3D-real IR MRI before and 4 hours after intravenous administration of a single dose of gadobutrol. Signal intensities of the cerebrospinal fluid (CSF), perilymph, and endolymph were manually measured on pre-contrast images using ROIs. Patients were categorized into 2 groups based on post-contrast imaging: those with significant EH and those without. Normalized signal intensities (nSIs) of the endolymph were calculated and compared between the groups using the Mann-Whitney U test. RESULTS: The nSIs of the vestibular endolymph on non-contrast 3D-real IR images were significantly lower in the group with significant EH compared to the group without EH (P  < 0.05), suggesting T1 prolongation in the vestibular endolymph of patients with significant EH. However, considerable overlap was observed in the nSIs between the 2 groups, and significant EH did not always result in T1 prolongation. No significant differences were found in the nSIs of the perilymph or CSF between the groups. CONCLUSION: The study suggests that T1 prolongation occurs in the vestibular endolymph in cases of significant EH. This finding indicates the potential for developing non-contrast MRI methods to detect EH and underscores the importance of understanding the mechanisms behind T1 changes in the endolymph. Further research with larger patient cohorts and inclusion of healthy control subjects is necessary to validate these results and to elucidate the pathophysiology of EH in Ménière's disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。